ArticleFrontiers in oncology2025
Data augmented lung cancer prediction framework using the nested case control NLST cohort.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Multimodal Deep Learning Approaches for Lung Disease Detection: A Review.Medicina (Kaunas, Lithuania) · 2026Review
- Diffusion models vs. DCGANs for class-imbalanced lung cancer CT classification: A comparative study.Intelligence-based medicine · 2026Article
- Diffusion Models vs. DCGANs for Class-Imbalanced Lung Cancer CT Classification: A Comparative Study.bioRxiv : the preprint server for biology · 2025Article
- Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges.MedComm · 2025Review
- Lung Cancer Diagnosis From Computed Tomography Images Using Deep Learning Algorithms With Random Pixel Swap Data Augmentation: Algorithm Development and Validation Study.JMIR bioinformatics and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: In the context of lung cancer screening, the scarcity of well-labeled medical images poses a significant challenge to implement supervised learning-based deep learning methods. While data augmentation is an effective technique for countering the difficulties caused by insufficient data, it has not been fully explored in the context of lung cancer screening. In this research study, we analyzed the state-of-the-art (SOTA) data augmentation techniques for lung cancer binary prediction. Methods: To comprehensively evaluate the efficiency of data augmentation approaches, we considered the nested case control National Lung Screening Trial (NLST) cohort comprising of 253 individuals who had the commonly used CT scans without contrast. The CT scans were pre-processed into three-dimensional volumes based on the lung nodule annotations. Subsequently, we evaluated five basic (online) and two generative model-based offline data augmentation methods with ten state-of-the-art (SOTA) 3D deep learning-based lung cancer prediction models. Results: Our results demonstrated that the performance improvement by data augmentation was highly dependent on approach used. The Cutmix method resulted in the highest average performance improvement across all three metrics: 1.07%, 3.29%, 1.19% for accuracy, F1 score and AUC, respectively. MobileNetV2 with a simple data augmentation approach achieved the best AUC of 0.8719 among all lung cancer predictors, demonstrating a 7.62% improvement compared to baseline. Furthermore, the MED-DDPM data augmentation approach was able to improve prediction performance by rebalancing the training set and adding moderately synthetic data. Conclusions: The effectiveness of online and offline data augmentation methods were highly sensitive to the prediction model, highlighting the importance of carefully selecting the optimal data augmentation method. Our findings suggest that certain traditional methods can provide more stable and higher performance compared to SOTA online data augmentation approaches. Overall, these results offer meaningful insights for the development and clinical integration of data augmented deep learning tools for lung cancer screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.